Founder and Chief Executive Officer of Injectable Stem Cell Product Manufacturer Sentenced for Distributing Unapproved Drug
The founder and chief executive officer of a California-based company that marketed stem cell-based products allegedly linked to 19 hospitalizations was sentenced today to 36 months in prison following his conviction under the Federal Food, Drug and Cosmetic Act.
Action Details
- Date:September 30, 2024
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions